It has been reported that stimulation of Tregs with anti‐CD3/CD28, rapamycin, or retinoic acid increases their proliferation and enhances their regulatory capacity, which could improve their function in the treatment of autoimmune diseases or transplant rejection.34 This evidence concerns the gene CD28 and autoimmune disease.